Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Relay Therapeutics, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES
Ticker
Exchange
SIC #
Website
Latest Ticker
RLAY
Nasdaq
2836
www.relaytx.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Relay Therapeutics, Inc.
Raymond James Updates Healthcare Top Picks for October
- Oct 1st, 2026 2:26 pm
Can Recursion Pharmaceuticals' Strategic Deals Fuel Long-Term Growth?
- Sep 24th, 2026 9:08 am
X-Chem Announces Phase 3 Milestone in Collaboration with Relay Therapeutics
- Sep 22nd, 2026 7:30 am
Can RXRX's Pipeline Expansion Strengthen Its Long-Term Growth Outlook?
- Sep 3rd, 2026 8:32 am
Relay Therapeutics CFO Sells 17,717 Shares for $350,000
- Sep 2nd, 2026 11:20 am
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in September
- Sep 1st, 2026 2:46 pm
This 'Dynamo' Biotech Puts AI-Fueled Breakout In Motion
- Aug 21st, 2026 1:43 pm
Relay Therapeutics (RLAY) Reported Q2 Results, Is The Premium P B Multiple Justified?
- Aug 19th, 2026 6:16 pm
The Zacks Analyst Blog Highlights Recursion Pharmaceuticals, Schrodinger, Relay Therapeutics and Absci
- Aug 18th, 2026 1:43 am
4 AI-Powered Drug Discovery Stocks to Watch as AI Reshapes Pharma
- Aug 17th, 2026 7:56 am
Relay Therapeutics Stock Is Up Nearly 500% Over the Past Year
- Aug 13th, 2026 9:00 am
Relay Therapeutics, Inc. (RLAY) Reports Q2 Loss, Lags Revenue Estimates
- Aug 6th, 2026 5:10 pm
Relay Therapeutics Reports Second Quarter 2026 Financial Results and Corporate Updates
- Aug 6th, 2026 2:05 pm
Shionogi & Co., Ltd. Unsponsored ADR (SGIOY) Beats Q1 Earnings Estimates
- Aug 3rd, 2026 5:10 am
Relay Therapeutics to Announce Second Quarter 2026 Financial Results and Corporate Highlights on August 6, 2026
- Jul 30th, 2026 2:05 pm
Relay Therapeutics, Inc. (RLAY) Expected to Beat Earnings Estimates: Should You Buy?
- Jul 30th, 2026 8:00 am
Relay Therapeutics Insider Sale Tops $3 Million as Shares Surge 500% This Past Year
- Jun 29th, 2026 6:12 pm
Relay Therapeutics (RLAY) is One of the Best AI Driven Biotech Stocks, Here is Why
- Jun 11th, 2026 4:20 am
Relay Therapeutics to Participate in Two Upcoming Investor Conferences in June
- May 27th, 2026 2:05 pm
Scroll